Bruno, R., Chanu, P., Kågedal, M., Mercier, F., Yoshida, K., Guedj, J., . . . Jin, J. Y. (2023). Support to early clinical decisions in drug development and personalised medicine with checkpoint inhibitors using dynamic biomarker-overall survival models. British Journal of Cancer, 129(9), 1383. https://doi.org/10.1038/s41416-023-02190-5
Chicago-referens (17:e uppl.)Bruno, René, Pascal Chanu, Matts Kågedal, Francois Mercier, Kenta Yoshida, Jérémie Guedj, Chunze Li, Ulrich Beyer, och Jin Y. Jin. "Support to Early Clinical Decisions in Drug Development and Personalised Medicine with Checkpoint Inhibitors Using Dynamic Biomarker-overall Survival Models." British Journal of Cancer 129, no. 9 (2023): 1383. https://doi.org/10.1038/s41416-023-02190-5.
MLA-referens (9:e uppl.)Bruno, René, et al. "Support to Early Clinical Decisions in Drug Development and Personalised Medicine with Checkpoint Inhibitors Using Dynamic Biomarker-overall Survival Models." British Journal of Cancer, vol. 129, no. 9, 2023, p. 1383, https://doi.org/10.1038/s41416-023-02190-5.
